A Case of Severe Acute Kidney Injury Exacerbated by Canagliflozin in a Patient with Type 2 Diabetes

BACKGROUND: Sodium glucose cotransport (SGLT)-2 inhibitors are the newest class of antihyperglycemic agents used as second- or third-line treatment in the management of type 2 diabetes. Although the use of SGLT-2 inhibitors has not been shown to cause nephrotoxicity, there have been case reports of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassani-Ardakania, Kimya, Lipman, Mark L., Laporta, Denny, Yu, Oriana Hoi Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582856/
https://www.ncbi.nlm.nih.gov/pubmed/31275667
http://dx.doi.org/10.1155/2019/8639629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582856/
https://www.ncbi.nlm.nih.gov/pubmed/31275667
http://dx.doi.org/10.1155/2019/8639629

Ejemplares similares